Knowledge

Tesaro

Source đź“ť

96: 85: 1188: 27: 216:– In February 2023, the FDA approved dostarlimab-gxly (Jemperli, GlaxoSmithKline LLC) for adults with mismatch repair deficient (dMMR) recurrent or advanced endometrial cancer, as determined by an FDA-approved test, that has progressed on or following a prior platinum-containing regimen in any setting and are not candidates for curative surgery or radiation. 181:
in October 2015. As of 2016, the company had 286 full-time employees, 59 of whom had a PhD or MD. The company's product Niraparib was granted priority review and was given a target action date of June 2017 by the FDA. In March 2017, Tesaro won approval for its drug Zejula to treat ovarian cancer. On
303: 404: 390: 1214: 1229: 1219: 326: 1254: 1224: 1249: 1125: 1234: 372: 593: 1118: 1244: 1239: 735: 508: 1132: 1139: 1156: 1065: 279: 255: 443: 1111: 473: 405:"2016 Press Release: Niraparib Significantly Improves Outcome of Ovarian Cancer Patients in Landmark Trial" 186:
announced it would acquire the company for $ 5.1 billion, and the deal was completed on January 22, 2019.
653: 344: 830: 84: 1167: 1060: 834: 717: 613: 603: 503: 198:– intravenous form in phase III clinical trials for use in chemotherapy-induced nausea and vomiting 95: 598: 376: 884: 673: 643: 158: 78: 67: 1161: 588: 513: 182:
May 31, 2017, it was reported that Tesaro Inc. was exploring a sale. On December 3, 2018,
8: 558: 349: 825: 917: 466: 320: 234: 608: 391:"GSK completes acquisition of TESARO, an oncology focused biopharmaceutical company" 308:, Street Insider, December 20, 2016, archived from the original on December 21, 2016 1259: 1191: 1016: 904: 1044: 1006: 1001: 668: 523: 583: 578: 573: 1080: 1026: 991: 125: 1208: 1075: 996: 663: 658: 563: 1085: 1070: 1021: 790: 459: 1034: 1011: 683: 213: 1090: 1039: 947: 899: 713: 703: 698: 688: 568: 195: 37: 1173: 957: 937: 894: 889: 869: 864: 805: 775: 755: 708: 693: 678: 201: 373:"GSK slides after buying cancer firm Tesaro for hefty $ 5.1 billion" 173:
Tesaro was founded in 2010. The company's first commercial product,
942: 932: 927: 922: 879: 815: 810: 785: 765: 750: 745: 648: 204:– PARP inhibitor in clinical trials for breast and ovarian cancer. 912: 874: 856: 820: 780: 760: 740: 482: 183: 130: 952: 800: 795: 770: 538: 174: 162: 108: 26: 430: 305:
ESARO (TSRO) Announces Priority FDA Review for Niraparib NDA
962: 178: 143: 451: 343:
D. Rockoff, Jonathan; Cimilluca, Dana (May 31, 2017).
342: 338: 336: 1206: 333: 325:: CS1 maint: bot: original URL status unknown ( 1126:GlaxoSmithKline Services Unlimited v Commission 379:on December 4, 2018 – via uk.reuters.com. 1215:Pharmaceutical companies of the United States 467: 189: 1230:Pharmaceutical companies established in 2010 1220:Health care companies based in Massachusetts 1255:American subsidiaries of foreign companies 474: 460: 94: 83: 25: 1225:Companies based in Waltham, Massachusetts 1250:Companies formerly listed on the Nasdaq 1119:Christopher v. SmithKline Beecham Corp. 1207: 594:Recherche et Industrie ThĂ©rapeutiques 455: 161:. They focus on drug development for 157:is a pharmaceutical company based in 1235:2010 establishments in Massachusetts 440:Historical business data for Tesaro: 509:GlaxoSmithKline Pharmaceuticals Ltd 13: 14: 1271: 1133:United States v. Glaxo Group Ltd. 422: 375:. 3 December 2018. Archived from 1187: 1186: 1140:United States v. GlaxoSmithKline 1157:Drug Industry Documents Archive 16:American pharmaceutical company 1112:Canada v. GlaxoSmithKline Inc. 397: 383: 365: 296: 272: 248: 227: 1: 1245:2019 mergers and acquisitions 1240:2012 initial public offerings 220: 7: 256:"TESARO - Quarterly Report" 57:; 14 years ago 10: 1276: 190:Products under development 168: 1182: 1149: 1103: 1053: 982: 975: 849: 728: 636: 629: 622: 614:Smith, Kline & French 549: 533: 496: 489: 353:. New York City, New York 138: 124: 114: 104: 73: 51: 43: 33: 24: 604:S. E. Massengill Company 504:GlaxoSmithKline Pakistan 280:"TESARO - Annual Report" 599:Reliant Pharmaceuticals 481: 345:"Tesaro Explores Sale" 177:, was approved by the 159:Waltham, Massachusetts 68:Waltham, Massachusetts 1162:GlaxoSmithKline Prize 589:Human Genome Sciences 559:Allen & Hanburys 514:Stiefel Laboratories 350:Wall Street Journal 116:Number of employees 92:United States  21: 1066:Silas M. Burroughs 609:SmithKline Beecham 574:Burroughs Wellcome 393:. 22 January 2019. 19: 1202: 1201: 1099: 1098: 971: 970: 845: 844: 545: 544: 152: 151: 1267: 1190: 1189: 1017:Patrick Vallance 980: 979: 709:Wellbutrin/Zyban 634: 633: 627: 626: 494: 493: 476: 469: 462: 453: 452: 434: 433: 431:Official website 416: 415: 413: 412: 401: 395: 394: 387: 381: 380: 369: 363: 362: 360: 358: 340: 331: 330: 324: 316: 315: 313: 300: 294: 293: 291: 290: 284:Ir.tesarobio.com 276: 270: 269: 267: 266: 260:Ir.tesarobio.com 252: 246: 245: 243: 242: 231: 148: 145: 99: 98: 88: 87: 65: 63: 58: 29: 22: 18: 1275: 1274: 1270: 1269: 1268: 1266: 1265: 1264: 1205: 1204: 1203: 1198: 1178: 1145: 1095: 1049: 1045:Laurie Glimcher 1012:Manvinder Banga 1007:Roy M. Anderson 1002:Simon Dingemans 984: 967: 841: 724: 618: 551: 541: 529: 524:ViiV Healthcare 485: 480: 448: 429: 428: 425: 420: 419: 410: 408: 403: 402: 398: 389: 388: 384: 371: 370: 366: 356: 354: 341: 334: 318: 317: 311: 309: 302: 301: 297: 288: 286: 278: 277: 273: 264: 262: 254: 253: 249: 240: 238: 237:. FierceBiotech 233: 232: 228: 223: 192: 171: 142: 133: 120:286 (2016) 117: 100: 93: 89: 82: 61: 59: 56: 47:Pharmaceuticals 17: 12: 11: 5: 1273: 1263: 1262: 1257: 1252: 1247: 1242: 1237: 1232: 1227: 1222: 1217: 1200: 1199: 1197: 1196: 1183: 1180: 1179: 1177: 1176: 1171: 1164: 1159: 1153: 1151: 1147: 1146: 1144: 1143: 1136: 1129: 1122: 1115: 1107: 1105: 1101: 1100: 1097: 1096: 1094: 1093: 1088: 1083: 1081:Henry Wellcome 1078: 1073: 1068: 1063: 1061:Thomas Beecham 1057: 1055: 1051: 1050: 1048: 1047: 1042: 1037: 1032: 1029: 1027:Lynn Elsenhans 1024: 1019: 1014: 1009: 1004: 999: 994: 992:Philip Hampton 988: 986: 977: 973: 972: 969: 968: 966: 965: 960: 955: 950: 945: 940: 935: 930: 925: 920: 918:Goody's Powder 915: 910: 907: 902: 897: 892: 887: 882: 877: 872: 867: 862: 859: 853: 851: 847: 846: 843: 842: 840: 839: 828: 823: 818: 813: 808: 803: 798: 793: 788: 783: 778: 773: 768: 763: 758: 753: 748: 743: 738: 732: 730: 726: 725: 723: 722: 711: 706: 701: 696: 691: 686: 681: 676: 671: 666: 661: 656: 651: 646: 640: 638: 631: 624: 620: 619: 617: 616: 611: 606: 601: 596: 591: 586: 584:Glaxo Wellcome 581: 576: 571: 566: 561: 555: 553: 547: 546: 543: 542: 537: 535: 531: 530: 528: 527: 521: 516: 511: 506: 500: 498: 491: 487: 486: 479: 478: 471: 464: 456: 450: 449: 447: 446: 441: 437: 435: 424: 423:External links 421: 418: 417: 396: 382: 364: 332: 295: 271: 247: 225: 224: 222: 219: 218: 217: 211: 208: 205: 199: 191: 188: 170: 167: 150: 149: 140: 136: 135: 134:(2019–present) 128: 122: 121: 118: 115: 112: 111: 106: 102: 101: 91: 77: 75: 71: 70: 53: 49: 48: 45: 41: 40: 35: 31: 30: 15: 9: 6: 4: 3: 2: 1272: 1261: 1258: 1256: 1253: 1251: 1248: 1246: 1243: 1241: 1238: 1236: 1233: 1231: 1228: 1226: 1223: 1221: 1218: 1216: 1213: 1212: 1210: 1195: 1194: 1185: 1184: 1181: 1175: 1172: 1170: 1169: 1165: 1163: 1160: 1158: 1155: 1154: 1152: 1148: 1142: 1141: 1137: 1135: 1134: 1130: 1128: 1127: 1123: 1121: 1120: 1116: 1114: 1113: 1109: 1108: 1106: 1102: 1092: 1089: 1087: 1084: 1082: 1079: 1077: 1076:John K. Smith 1074: 1072: 1069: 1067: 1064: 1062: 1059: 1058: 1056: 1052: 1046: 1043: 1041: 1038: 1036: 1033: 1031:Jesse Goodman 1030: 1028: 1025: 1023: 1020: 1018: 1015: 1013: 1010: 1008: 1005: 1003: 1000: 998: 997:Emma Walmsley 995: 993: 990: 989: 987: 981: 978: 974: 964: 961: 959: 956: 954: 951: 949: 946: 944: 941: 939: 936: 934: 931: 929: 926: 924: 921: 919: 916: 914: 911: 908: 906: 903: 901: 898: 896: 893: 891: 888: 886: 883: 881: 878: 876: 873: 871: 868: 866: 863: 860: 858: 855: 854: 852: 848: 838: 837: 832: 829: 827: 824: 822: 819: 817: 814: 812: 809: 807: 804: 802: 799: 797: 794: 792: 789: 787: 784: 782: 779: 777: 774: 772: 769: 767: 764: 762: 759: 757: 754: 752: 749: 747: 744: 742: 739: 737: 734: 733: 731: 727: 721: 720: 715: 712: 710: 707: 705: 702: 700: 697: 695: 692: 690: 689:Paxil/Seroxat 687: 685: 682: 680: 677: 675: 672: 670: 667: 665: 662: 660: 657: 655: 652: 650: 647: 645: 642: 641: 639: 635: 632: 628: 625: 621: 615: 612: 610: 607: 605: 602: 600: 597: 595: 592: 590: 587: 585: 582: 580: 577: 575: 572: 570: 567: 565: 564:Beecham Group 562: 560: 557: 556: 554: 550:Predecessors, 548: 540: 536: 532: 525: 522: 520: 517: 515: 512: 510: 507: 505: 502: 501: 499: 495: 492: 488: 484: 477: 472: 470: 465: 463: 458: 457: 454: 445: 442: 439: 438: 436: 432: 427: 426: 406: 400: 392: 386: 378: 374: 368: 352: 351: 346: 339: 337: 328: 322: 307: 306: 299: 285: 281: 275: 261: 257: 251: 236: 230: 226: 215: 212: 209: 206: 203: 200: 197: 194: 193: 187: 185: 180: 176: 166: 164: 160: 156: 147: 141: 137: 132: 129: 127: 123: 119: 113: 110: 107: 103: 97: 86: 80: 76: 72: 69: 54: 50: 46: 42: 39: 36: 32: 28: 23: 1192: 1168:Side Effects 1166: 1138: 1131: 1124: 1117: 1110: 1086:Andrew Witty 1071:Mahlon Kline 1022:Vivienne Cox 835: 791:H5N1 vaccine 718: 552:acquisitions 518: 490:Subsidiaries 409:. Retrieved 399: 385: 377:the original 367: 355:. Retrieved 348: 310:, retrieved 304: 298: 287:. Retrieved 283: 274: 263:. Retrieved 259: 250: 239:. Retrieved 229: 172: 154: 153: 74:Headquarters 34:Company type 20:Tesaro, Inc. 1035:Judy Lewent 444:SEC filings 214:Dostarlimab 155:Tesaro Inc. 1209:Categories 1104:Litigation 1091:Chris Gent 1040:Urs Rohner 948:Parodontax 756:Engerix-B 569:Block Drug 411:2017-02-25 289:2017-02-25 265:2017-02-25 241:2017-02-25 221:References 196:Rolapitant 38:Subsidiary 1174:Study 329 985:Directors 983:Board of 958:Sensodyne 938:Nicorette 895:Emergen-C 890:ChapStick 870:BC Powder 865:Aquafresh 806:Pandemrix 776:Hepatyrix 674:Flixonase 654:Augmentin 202:Niraparib 144:tesarobio 1193:Category 943:NiQuitin 933:Nicoderm 928:Lucozade 923:Horlicks 905:Excedrin 880:Caltrate 826:Shingrix 816:Rabavert 811:Pediarix 786:Infanrix 766:FluLaval 751:Cervarix 746:Boostrix 729:Vaccines 704:Ventolin 694:Serlipet 684:Lamictal 679:Hycamtin 664:Beconase 623:Products 321:citation 235:"Tesaro" 105:Products 44:Industry 1260:GSK plc 913:Geritol 909:Flonase 885:Centrum 875:Biotene 857:Actifed 831:Twinrix 821:Rotarix 781:Hiberix 761:Fluarix 741:Bexsero 699:Tagamet 659:Avandia 630:Current 497:Current 357:June 1, 312:June 8, 210:TSR-022 207:TSR-042 169:History 139:Website 79:Waltham 60: ( 52:Founded 976:People 953:Ribena 850:Former 801:Menveo 796:Kinrix 771:Havrix 736:Arexvy 714:Zantac 669:Boniva 644:Advair 637:Pharma 539:Haleon 534:Former 519:Tesaro 407:. ESMO 175:Varubi 163:cancer 126:Parent 109:Varubi 81:  1150:Other 1054:Other 861:Advil 579:Glaxo 526:(85%) 66:, in 963:Tums 836:more 719:more 649:Alli 359:2017 327:link 314:2017 146:.com 62:2010 55:2010 900:Eno 483:GSK 184:GSK 179:FDA 131:GSK 1211:: 833:… 716:… 347:. 335:^ 323:}} 319:{{ 282:. 258:. 165:. 90:, 475:e 468:t 461:v 414:. 361:. 329:) 292:. 268:. 244:. 64:)

Index


Subsidiary
Waltham, Massachusetts
Waltham
Edit this on Wikidata
Edit this on Wikidata
Varubi
Parent
GSK
tesarobio.com
Waltham, Massachusetts
cancer
Varubi
FDA
GSK
Rolapitant
Niraparib
Dostarlimab
"Tesaro"
"TESARO - Quarterly Report"
"TESARO - Annual Report"
ESARO (TSRO) Announces Priority FDA Review for Niraparib NDA
citation
link


"Tesaro Explores Sale"
Wall Street Journal
"GSK slides after buying cancer firm Tesaro for hefty $ 5.1 billion"
the original

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

↑